A library of 159 FDA-approved compounds. Comprises a subset of the Tocriscreen Plus (Cat. No. 5840) compound library. Contains compounds covering a range of therapeutic classes e.g. the cardiovascular and nervous systems and research areas such as cancer and immunology. Includes both established gold-standard compounds, e.g. tamoxifen, paclitaxel, as well as more recent highly selective, targeted compounds, such as gefitinib and axitinib.